本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

6.94
+0.14002.06%
成交量:1.92万
成交额:13.08万
市值:4,270.60万
市盈率:-0.51
高:7.19
开:6.85
低:6.58
收:6.80
52周最高:18.75
52周最低:3.76
股本:615.36万
流通股本:300.20万
量比:0.54
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-13.5400
每股收益(LYR):-20.9448
净资产收益率:-141.82%
总资产收益率:-54.70%
市净率:0.59
市盈率(LYR):-0.33

数据加载中...

公司资料

公司名字:
Aligos Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
70
公司地址:
One Corporate Drive,2nd Floor,South San Francisco,California,United States
邮编:
94080
电话:
传真:
- -
简介:
Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发新疗法,以解决肝病和病毒感染方面未满足的医疗需求。

董事

名称
职位
Lawrence M. Blatt
Chair,President and Chief Executive Officer
Bridget Martell
Director
Carole Nuechterlein
Director
Heather Preston
Director
James Scopa
Director
K. Peter Hirth
Director
Margarita Chavez
Director

股东

名称
职位
Lawrence M. Blatt
Chair,President and Chief Executive Officer
Lesley Ann Calhoun
Executive Vice President,Chief Operating Officer and Chief Financial Officer
Hardean E. Achneck
Executive Vice President and Chief Medical Officer
Julian A. Symons
Executive Vice President and Chief Scientific Officer
Nikhil Aneja
Principal Accounting Officer